These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34752621)

  • 21. Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome.
    Sir-Petermann T; Codner E; Pérez V; Echiburú B; Maliqueo M; Ladrón de Guevara A; Preisler J; Crisosto N; Sánchez F; Cassorla F; Bhasin S
    J Clin Endocrinol Metab; 2009 Jun; 94(6):1923-30. PubMed ID: 19223518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study.
    Celik C; Tasdemir N; Abali R; Bastu E; Yilmaz M
    Fertil Steril; 2014 Apr; 101(4):1123-8.e1. PubMed ID: 24502891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DPP4 INHIBITOR SITAGLIPTIN AS A POTENTIAL TREATMENT OPTION IN METFORMIN-INTOLERANT OBESE WOMEN WITH POLYCYSTIC OVARY SYNDROME: A PILOT RANDOMIZED STUDY.
    Ferjan S; Janez A; Jensterle M
    Endocr Pract; 2018 Jan; 24(1):69-77. PubMed ID: 29144805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early impaired β-cell function in chinese women with polycystic ovary syndrome.
    Tao T; Li S; Zhao A; Mao X; Liu W
    Int J Clin Exp Pathol; 2012; 5(8):777-86. PubMed ID: 23071860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sex hormone binding globulin, but not testosterone, is associated with the metabolic syndrome in overweight and obese women with polycystic ovary syndrome.
    Moran LJ; Teede HJ; Noakes M; Clifton PM; Norman RJ; Wittert GA
    J Endocrinol Invest; 2013 Dec; 36(11):1004-10. PubMed ID: 23812344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polycystic ovary syndrome and abnormalities in glucose tolerance.
    Bhattacharya SM
    Int J Gynaecol Obstet; 2009 Apr; 105(1):29-31. PubMed ID: 19155002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of plasma insulin and insulin-like growth factor-I with indices of androgen transport and metabolism in women with polycystic ovary syndrome.
    Sharp PS; Kiddy DS; Reed MJ; Anyaoku V; Johnston DG; Franks S
    Clin Endocrinol (Oxf); 1991 Sep; 35(3):253-7. PubMed ID: 1742883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-Müllerian hormone levels in peripubertal daughters of women with polycystic ovary syndrome.
    Crisosto N; Codner E; Maliqueo M; Echiburú B; Sánchez F; Cassorla F; Sir-Petermann T
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2739-43. PubMed ID: 17488788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in first-degree relatives of subjects with polycystic ovary syndrome.
    Yilmaz M; Ergün MA; Karakoç A; Yurtçu E; Yetkin I; Ayvaz G; Cakir N; Arslan M
    Gynecol Endocrinol; 2005 Oct; 21(4):206-10. PubMed ID: 16316841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic and hormonal changes induced by pioglitazone in polycystic ovary syndrome: a randomized, placebo-controlled clinical trial.
    Aroda VR; Ciaraldi TP; Burke P; Mudaliar S; Clopton P; Phillips S; Chang RJ; Henry RR
    J Clin Endocrinol Metab; 2009 Feb; 94(2):469-76. PubMed ID: 18984667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Profiles in Reproductive-Age Women with Polycystic Ovary Syndrome: A Large Canadian Cohort.
    Kazemi M; Pierson RA; Lujan ME; Chilibeck PD; McBreairty LE; Gordon JJ; Serrao SB; Zello GA; Chizen DR
    J Obstet Gynaecol Can; 2019 Oct; 41(10):1453-1460. PubMed ID: 30712903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 17-hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome.
    Pasquali R; Patton L; Pocognoli P; Cognigni GE; Gambineri A
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4208-17. PubMed ID: 17785360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Normal Pubertal Development in Daughters of Women With PCOS: A Controlled Study.
    Legro RS; Kunselman AR; Stetter CM; Gnatuk CL; Estes SJ; Brindle E; Vesper HW; Botelho JC; Lee PA; Dodson WC
    J Clin Endocrinol Metab; 2017 Jan; 102(1):122-131. PubMed ID: 27778640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome.
    Ezeh U; Pall M; Mathur R; Azziz R
    Hum Reprod; 2014 Jul; 29(7):1508-17. PubMed ID: 24813197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dyslipidemia and metabolic syndrome in the sisters of women with polycystic ovary syndrome.
    Sam S; Legro RS; Bentley-Lewis R; Dunaif A
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4797-802. PubMed ID: 15899949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Degree of Menstrual Disturbance Is Associated With the Severity of Insulin Resistance in PCOS.
    Li X; Yang D; Pan P; Azziz R; Yang D; Cheng Y; Zhao X
    Front Endocrinol (Lausanne); 2022; 13():873726. PubMed ID: 35769085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cross-sectional analysis of the effects of age on the hormonal, metabolic, and ultrasonographic features and the prevalence of the different phenotypes of polycystic ovary syndrome.
    Panidis D; Tziomalos K; Macut D; Delkos D; Betsas G; Misichronis G; Katsikis I
    Fertil Steril; 2012 Feb; 97(2):494-500. PubMed ID: 22192350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.
    Ehrmann DA; Barnes RB; Rosenfield RL; Cavaghan MK; Imperial J
    Diabetes Care; 1999 Jan; 22(1):141-6. PubMed ID: 10333916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance.
    Holte J; Bergh T; Berne C; Berglund L; Lithell H
    J Clin Endocrinol Metab; 1994 May; 78(5):1052-8. PubMed ID: 8175959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.